Sajkowski Daniel J 4/A

What Happened Daniel J. Sajkowski, a director of Calumet, Inc. (CLMT), had 5,053 restricted stock units (RSUs) convert/“exercise” on December 4, 2025. The Form 4 (amended) reports an exercise/conversion of 5,053 derivative units (code M) and a simultaneous open-market sale of 2,022 shares (code S). The filing reports $0.00 per-share for these entries; cash values for the settlement are not disclosed in the Form 4.

Key Details

• Transaction date: December 4, 2025; amended Form 4 filed February 26, 2026 (late/amended filing).
• Reported actions: Exercise/conversion of 5,053 RSUs (M); open-market sale of 2,022 shares (S); a derivative disposition of 5,053 units also reported.
• Reported prices/values: $0.00 per share as shown on the Form 4; actual cash settlement amounts are not disclosed in this filing.
• Shares owned after transaction: Not specified in the amended filing.
• Footnotes: F1–F3 state Sajkowski elected to receive 40% of the vested RSUs in the cash equivalent of Calumet common stock; each RSU equals one share and RSUs were 100% vested.
• Filing status: This is an amended, late-filed Form 4 (original transaction date Dec 4, 2025; filing date Feb 26, 2026).

Context RSUs are compensation awards that convert to shares or cash when they vest. Here, the director’s RSUs were fully vested and partially settled in cash (40% as noted), while a portion of shares was sold on the open market—commonly done to cover taxes or convert compensation to cash. The $0.00 reporting on the Form 4 means the filing does not show the cash amounts; therefore the economic value to the insider isn’t available from this document alone. This appears to be a routine compensation settlement rather than a standalone market-timing purchase.